Compare PLOW & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLOW | BCYC |
|---|---|---|
| Founded | 1948 | 2009 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 732.0M | 438.4M |
| IPO Year | 2010 | 2019 |
| Metric | PLOW | BCYC |
|---|---|---|
| Price | $33.94 | $7.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 11 |
| Target Price | ★ $39.00 | $18.73 |
| AVG Volume (30 Days) | 144.3K | ★ 303.3K |
| Earning Date | 11-03-2025 | 10-30-2025 |
| Dividend Yield | ★ 3.47% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | ★ $615,064,000.00 | $28,339,000.00 |
| Revenue This Year | $15.07 | N/A |
| Revenue Next Year | $10.40 | N/A |
| P/E Ratio | $19.45 | ★ N/A |
| Revenue Growth | ★ 9.99 | N/A |
| 52 Week Low | $21.30 | $6.03 |
| 52 Week High | $34.41 | $21.21 |
| Indicator | PLOW | BCYC |
|---|---|---|
| Relative Strength Index (RSI) | 67.52 | 55.07 |
| Support Level | $31.87 | $7.03 |
| Resistance Level | $32.61 | $7.65 |
| Average True Range (ATR) | 0.75 | 0.38 |
| MACD | 0.24 | 0.10 |
| Stochastic Oscillator | 85.19 | 73.86 |
Douglas Dynamics Inc is a manufacturer and upfitter of commercial vehicle attachments and equipment. The Company's portfolio includes snow and ice management attachments sold under the BLIZZARD, FISHER, HENDERSON, SNOWEX, and WESTERN brands, turf care equipment under the TURFEX brand, and industrial maintenance equipment under the SWEEPEX brand. The Company's portfolio also includes the upfit of attachments and storage solutions under the HENDERSON brand, and the DEJANA brand and its related sub-brands. The Company also leases fifteen manufacturing upfit and service facilities located in Iowa, Maryland, Missouri, New Jersey, New York, Ohio, Pennsylvania, and Rhode Island. The Company conducts business in two segments: Work Truck Attachments and Work Truck Solutions.
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.